STOCK TITAN

abrdn Healthcare Opportunities Fund Paid Distribution

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags
Rhea-AI Summary
abrdn Healthcare Opportunities Fund, formerly known as Tekla Healthcare Opportunities Fund, paid a monthly distribution of $0.1125 per share on October 31, 2023. The distribution is derived from a return of capital or other capital source. The Fund estimates that it has distributed more than its income and net realized capital gains, indicating a potential return of capital.
Positive
  • None.
Negative
  • None.

BOSTON--(BUSINESS WIRE)-- On October 31, 2023, abrdn Healthcare Opportunities Fund, formerly known as Tekla Healthcare Opportunities Fund, paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from a return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. As of October 26, 2023, the aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $14,255,566, of which $15,246,483 represents net unrealized appreciation of portfolio securities.

The following table sets forth the estimated amounts of the current distribution, paid on October 31, 2023, and the cumulative distributions paid this fiscal year-to-date from the following sources: net investment income, net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. The Fund estimates that it has distributed more than its income and net realized capital gains; therefore, a portion of your distribution may be a return of capital. A return of capital may occur, for example, when some or all the money that you have invested in the Fund is paid back to you. A return of capital distribution does not necessarily reflect the Fund’s investment performance and should not be confused with ‘yield’ or ‘income’. All amounts are expressed per common share.

 

 

Current
Distribution

 

Percentage
Breakdown of
Current Distribution

 

Total Cumulative
Distributions for the
Fiscal Year to Date1

 

Percentage Breakdown
of the Total Cumulative
Distributions for the
Fiscal Year to Date1

Net Investment Income

 

$0.0000

 

0%

 

$0.0000

 

0%

Net Realized ST Cap Gains

 

$0.0000

 

0%

 

$0.0000

 

0%

Net Realized LT Cap Gains

 

$0.0000

 

0%

 

$0.0000

 

0%

Return of Capital or Other Capital Source

 

$0.1125

 

100%

 

$0.1125

 

100%

TOTAL (per common share):

 

$0.1125

 

100%

 

$0.1125

 

100%

The table below includes information relating to the Fund’s performance based on its NAV for certain periods.

Average annual return at NAV for the period from September 30, 2018 through September 30, 2023

 

6.19%

Annualized current distribution rate expressed as a percentage of NAV as of September 30, 2023

 

6.71%

Cumulative total return at NAV for the fiscal year through September 30, 20232

 

6.94%

Cumulative fiscal year-to-date distribution rate expressed as a percentage of NAV as of September 30, 2023

 

6.71%

You should not draw any conclusions about the Fund’s investment performance from the amount of this distribution or from the terms of the Fund’s managed distribution policy.

The amounts and sources of distributions reported in this press release are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund’s investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.

abrdn Healthcare Opportunities Fund (NYSE: THQ) is a closed-end fund that invests in companies in the healthcare industry.

For more information, please go to www.abrdnTHQ.com.

1

 

The Fund’s current fiscal year began on October 1, 2023.

2

 

Cumulative total return at NAV is the percentage change in the Fund’s NAV and includes all distributions and assumes the reinvestment of those distributions for the period of September 30, 2022 through September 30, 2023.

 

Investor Relations

investor.relations@abrdn.com

1-800-522-5465

Source: abrdn Healthcare Opportunities Fund

FAQ

What is the name of the healthcare fund mentioned in the press release?

The healthcare fund mentioned in the press release is abrdn Healthcare Opportunities Fund, formerly known as Tekla Healthcare Opportunities Fund.

What was the amount of the monthly distribution per share?

The monthly distribution per share was $0.1125.

What is the source of the distribution?

The distribution is derived from a return of capital or other capital source.

Has the fund distributed more than its income and net realized capital gains?

Yes, the fund estimates that it has distributed more than its income and net realized capital gains.

What does a return of capital distribution mean?

A return of capital distribution occurs when some or all of the money invested in the fund is paid back to the investor. It does not necessarily reflect the fund's investment performance and should not be confused with yield or income.

abrdn Healthcare Opportunities Fund

NYSE:THQ

THQ Rankings

THQ Latest News

THQ Stock Data

818.85M
41.34M
0%
20.76%
0.04%
Asset Management
Financial Services
Link
United States of America
Boston

About THQ

tekla life sciences investors is a closed-ended equity mutual fund launched and managed by tekla capital management llc. the fund invests in public equity markets across the globe. it seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. the fund primarily invests in growth stocks of small cap companies. it employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. the fund benchmarks the performance of its portfolio against the nasdaq biotech index and the s&p 500 index. it was form